Post-marketing Surveillance of Ofev Capsules in Chronic (PMS for PF-ILD)

First published 04/08/2020

Last updated 21/10/2026

EU PAS number:

EUPAS36605

Study

Finalised

Download as PDF

Documents

Study protocol

Initial protocol

Protocol_and_Protocol_Amendment_30_Sep_2025__Redacted.pdf

English (383.07 KB - PDF) View document

Study results

1199-0402_Synopsis.pdf

English (242.56 KB - PDF) View document

Study report

No information provided.

ENCePP Seal

The use of the ENCePP Seal has been discontinued since February 2025. The ENCePP Seal fields are retained in the display mode for transparency but are no longer maintained.

No information provided.

Post-marketing Surveillance of Ofev Capsules in Chronic (PMS for PF-ILD)

Secondary tabs

Share this page